Hike Medical has raised $22.5 million in combined seed and Series A funding to expand an automated referral and supply-chain platform serving orthotics, prosthetics and durable medical equipment providers. Saga Ventures led the round, with participation from Indicator Ventures, Fifth Down Capital, RiverPark Ventures, orthotics brand Orthofeet and a group of individual investors, bringing meaningful category expertise alongside the capital itself.
The San Francisco-based company is tackling a healthcare problem that attracts considerably less venture attention than pharmaceutical innovation or diagnostic technology: the often cumbersome, paperwork-heavy process of moving physical medical devices from providers to the patients who need them. For anyone who has waited weeks for a custom orthotic device or navigated the fragmented referral process between physicians, device manufacturers and insurance administrators, the operational inefficiency Hike Medical is targeting will be immediately familiar, even if it rarely attracts the same headlines as drug discovery breakthroughs.
Hike says it has already proven its model within custom foot orthotics, a category requiring precise measurement, manufacturing coordination and fitting logistics that make it a particularly demanding initial use case to solve well. Having established that foundation, the company now intends to extend its platform across the broader device-based care category, encompassing prosthetics and the wider durable medical equipment market that similarly depends on coordinating physicians, manufacturers, insurers and patients through processes that have historically relied heavily on fax machines, phone calls and manual paperwork.
The opportunity Hike Medical is pursuing sits at the intersection of healthcare administration, logistics and workflow software — a combination that has attracted growing investor attention as healthcare technology funding has increasingly shifted away from purely clinical AI applications toward the less glamorous but often more immediately monetisable administrative layer of the healthcare system, where labour costs and fragmented legacy software systems create substantial addressable spending that technology can plausibly reduce without requiring new clinical evidence or regulatory approval pathways.
Orthofeet's participation as both an investor and, implicitly, a potential channel partner is a notable detail. Strategic investment from an established orthotics brand suggests genuine industry validation of Hike Medical's approach, and could provide the startup with valuable initial distribution and credibility within a device manufacturer and provider community that might otherwise be sceptical of an outside software company attempting to restructure their referral and fulfilment workflows.
Healthcare's administrative inefficiency has long been recognised as one of the sector's largest sources of avoidable cost, yet solutions targeting this layer have historically struggled to attract the same investor enthusiasm as more clinically oriented healthcare AI, partly because the return on investment, while real, is often less dramatic and headline-worthy than claims of improved diagnostic accuracy or treatment outcomes. Hike Medical's ability to demonstrate measurable reductions in referral turnaround time and administrative burden for its device-manufacturer and provider customers will likely prove more persuasive to future investors and customers alike than any broader narrative about healthcare AI's transformative potential.
As the company extends beyond its initial orthotics use case into the broader durable medical equipment category, it will need to navigate the considerable variation in referral and reimbursement processes across different device categories and insurance frameworks — a complexity that has historically made building a single, unified platform for device-based care referrals more difficult than it might initially appear, even for well-capitalised healthcare technology companies.
For patients ultimately waiting on orthotics, prosthetics or other durable medical equipment, faster and more reliable coordination between the various parties involved in device fulfilment translates directly into improved quality of life and mobility outcomes — a tangible, human benefit that underpins the otherwise unglamorous administrative technology Hike Medical has built its business around.
The broader durable medical equipment industry in the United States has long been characterised by a fragmented supplier base, complex and often inconsistent insurance reimbursement rules, and referral processes that frequently depend on manual coordination between physicians' offices, device manufacturers and third-party logistics providers. That fragmentation has historically made it difficult for any single company to build a comprehensive solution spanning the full referral-to-fulfilment pipeline, a gap Hike Medical appears to be attempting to close by building infrastructure that can plug into multiple points along that chain simultaneously.
Saga Ventures' decision to lead this round, alongside a syndicate that includes both traditional venture funds and an industry-specific strategic investor in Orthofeet, reflects an increasingly common structure for healthcare infrastructure startups: pairing financial capital with genuine domain expertise and channel access that can meaningfully accelerate a young company's credibility within a conservative, relationship-driven industry where new vendors often face lengthy trust-building periods before established providers and manufacturers are willing to shift their existing referral workflows.
As Hike Medical works to extend its platform beyond custom foot orthotics into the broader durable medical equipment category, the company will likely need to demonstrate that the operational playbook proven within one relatively narrow device category — precise measurement, manufacturing coordination, fitting logistics — can generalise effectively across the far more heterogeneous universe of prosthetics and durable medical equipment, each carrying distinct manufacturing timelines, fitting requirements and reimbursement structures that may not map cleanly onto lessons learned from its initial orthotics-focused product.
Indicator Ventures, Fifth Down Capital and RiverPark Ventures rounding out the investor syndicate alongside Saga Ventures and Orthofeet gives Hike Medical a broad base of institutional support heading into its next phase of category expansion, an investor diversity that could prove useful should the company need to raise a larger, more capital-intensive round to fund the operational infrastructure required for scaling across additional device categories nationally.
The broader trajectory of healthcare technology investment over the past several years has shown a marked shift away from purely consumer-facing digital health applications, many of which struggled to demonstrate durable engagement or clear reimbursement pathways, toward infrastructure and workflow software serving providers, payers and device manufacturers directly. Hike Medical's positioning within that latter category — solving a genuine, quantifiable operational pain point for an established industry rather than attempting to change consumer health behaviour — reflects a more conservative but arguably more commercially durable strategy than many of the direct-to-consumer digital health startups that dominated headlines during the sector's earlier funding peak.
